title: Lung transplantation--10-year experience.
abstract: OBJECTIVE
  The experience at our institution with various forms of lung transplantation (heart-lung, double lung and single lung) from December 1987 to September 1998 is reviewed and discussed.
  
  
  METHODS
  During this decade, 282 procedures (46 heart-lungs (HLTx), 142 double lungs (DLTx) and 94 single lungs (SLTx)) have been performed in 258 patients (140 male, 118 female; age: 38 +/- 13 years). Major indications included pulmonary fibrosis (n = 73), obstructive lung disease (n = 55), cystic fibrosis (n = 48), primary pulmonary hypertension (n = 36), secondary pulmonary hypertension (majority Eisenmenger's syndrome) (n = 30), and retransplantation (n = 24).
  
  
  RESULTS
  Early postoperative mortality (<90 days) was 13.9% (n = 36). The 1-, 3-, and 5-year survival rates in all recipients was 77, 70 and 63%, respectively. There was no significant difference in 1-year survival rates between the different procedures (HLTx: 78%, DLTx: 77%, SLTx: 77%). Significantly better 1-year survival was achieved in patients with cystic fibrosis (89%), pulmonary fibrosis (81%), obstructive lung disease (74%), and Eisenmenger's syndrome (83%) when compared to patients with primary pulmonary hypertension (55%). Survival rates remained unchanged during this period despite expanding indications during the last years. Causes of death in 90 recipients (HLTx: n = 19, DLTx: n = 37, SLTx: n = 34) included sepsis (n = 42), obliterative bronchiolitis (n = 28), cardiac failure (n = 5), and early allograft dysfunction (n = 2). Freedom from bronchiolitis obliterans syndrome (BOS) (>stage I ISHLT) was 80% at 1 year and 45% at 5 years.
  
  
  CONCLUSIONS
  Lung transplantation offers a true therapeutic option with good early and midterm results. Yet, chronic graft dysfunction represents a major obstacle for long-term benefit of this procedure.
authors.affiliation: Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany. harringer@thg.mh-hannover.de
authors.forename: W
authors.initials: W
authors.lastname: Harringer
authors.forename: K
authors.initials: K
authors.lastname: Wiebe
authors.forename: M
authors.initials: M
authors.lastname: Strüber
authors.forename: U
authors.initials: U
authors.lastname: Franke
authors.forename: J
authors.initials: J
authors.lastname: Niedermeyer
authors.forename: H
authors.initials: H
authors.lastname: Fabel
authors.forename: A
authors.initials: A
authors.lastname: Haverich
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001989:Bronchiolitis Obliterans / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002423:Cause of Death; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D005858:Germany / Q000453:epidemiology; D006084:Graft Rejection / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006085:Graft Survival; D006306:Health Surveys; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis; D018709:Statistics, Nonparametric; D016019:Survival Analysis